Status:
UNKNOWN
The Metabolic Impact of Bariatric Surgery Compared to Best Diabetic Care on Manitoba's Urban Indigenous Population
Lead Sponsor:
University of Manitoba
Conditions:
Type2 Diabetes Mellitus
Obesity
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
Obesity and type 2 diabetes mellitus (T2DM) are major global health concerns as they commonly co-occur and are associated with significant morbidity, mortality, and health care expenditures. The Indig...
Detailed Description
Obesity and type 2 diabetes mellitus (T2DM) are major global health concerns as they commonly co-occur and are associated with significant morbidity, mortality, and health care expenditures. The Indig...
Eligibility Criteria
Inclusion
- Urban Indigenous patient
- 18 to 55 years of age
- male of female
- Body Mass Index = or \> 35 to 55 Kg/m2
- Confirmed diagnosis of Type II diabetes mellitus (HbA1c of 7.0% for at least one year)
- Referred and accepted as into the Centre for Metabolic and Bariatric Surgery Program
Exclusion
- Currently a smoker
- Body Mass Index above 55 Kg/m2
- Diagnosed with Type I diabetes mellitus
- Have had previous bariatric surgery
- Have contraindications to laparoscopic and/or bariatric surgery
- Rural patients; due to lack of rural Indigenous community-based support necessary for bariatric surgery
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03301545
Start Date
July 1 2020
End Date
December 31 2022
Last Update
April 6 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.